| (210) | Number of the EPO application | 17707527 |
| (220) | Filing date of the EPO application | 2017.02.24 |
| (80) | EPO patent specification publication (B) | EPB nr. 01/2021, 2021.01.06 |
| (110) | EPO patent number | 3419595 |
| (11) | Number of the document | MD 3419595 T2 |
| (21) | Number of the application | e 2019 0039 |
| (71) | Name(s) of applicant(s), code of the country | FERRING B.V., NL; |
| (72) | Name(s) of inventor(s), code of the country | SJÖGREN Helen Ulrika, SE;
HØJER-PEDERSEN Charlotte, DK; |
| (73) | Name(s) of owner(s), code of the country | FERRING B.V., NL; |
| (54) | Title of the invention | Stable liquid gonadotropin formulation |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 9/00 (2006.01.01); A61K 9/08 (2006.01.01); A61K 47/18 (2017.01.01) |
| (19) | Country | NL |
| (41) | Date of publication of the application | 2019.02.28 |
| (49) | Date of publication of the translation of the validated European patent specification | 2021.06.30 |
| (30) | Priority | 201603280, 2016.02.24, GB |
| (74) | Patent attorney | (Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova |
| (86) | International application | PCT/EP2017/054325, 2017.02.24 |
| (87) | International publication | WO 2017/144659, 2017.08.31 |